TRx0014 in Patients With Mild or Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

323

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Dementia, Alzheimer Type

Interventions

DRUG

TRx0014

Hard capsule; 60 milligrams; t.i.d.

DRUG

TRx0014

Hard capsule; 30 milligrams; t.i.d.

DRUG

Placebo

Hard capsule; 0 milligrams; t.i.d.

DRUG

TRx0014

Hard capsule, 100 milligrams, t.i.d.

All Listed Sponsors

lead

TauRx Therapeutics Ltd

INDUSTRY

NCT00515333 - TRx0014 in Patients With Mild or Moderate Alzheimer's Disease | Biotech Hunter | Biotech Hunter